Lv2
160 积分 2026-05-19 加入
Optimal Timing of GLP-1 Receptor Agonist Initiation in Patients with Obesity Eligible for Metabolic Bariatric Surgery
11天前
已完结
Combination therapy in metabolic dysfunction-associated steatohepatitis
14天前
已关闭
Beyond weight loss: multisystem benefits of obesity medications
20天前
已完结
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
20天前
已完结
Metabolic implications of hepatic, pancreatic and abdominal adipose tissue depots in Asian Indians across normoglycaemia, prediabetes and type 2 diabetes
22天前
已完结
Gastroparesis
22天前
已完结
Bulimia nervosa
25天前
已完结
A novel unimolecular GLP1 and amylin receptor agonist for glucose and weight control
25天前
已完结
Peripheral artery disease: advances in medical therapy
26天前
已完结
Sleep Health and Obesity
26天前
已完结
皖公网安备34019202002308
